Predicting Severity and Outcome of Covid-19 Infection Using Blood Parameters Estimated at the Time of Hospital Admission: A Retrospective Study
DOI:
https://doi.org/10.37506/f702tf10Keywords:
covid 19, Neutrophil-Lymphocyte ratio, Lymphocyte-Monocyte Ratio, Platelet -Lymphocyte Ratio, CURB-65Abstract
Introduction
Certain blood parameters can help in assessing the prognosis and severity of Covid-19 infection which can help in risk stratification on presentation to healthcare facilities. This study thus elicited the predictors of severe outcomes of Covid-19 among patients by measuring certain blood parameters at the time of admission.
Methodology
This retrospective study collected secondary data of 559 patients admitted in a tertiary care hospital in West Bengal during November 2020 to February 2022. Severity of Covid-19 infection was assessed using CURB-65 scoring. Factors associated were analyzed using Chi-
square test, Mann-Whitney U test and logistic regression analysis. Receiver Operator Characteristic (ROC) curves were plotted to determine the predictability of disease severity and in-hospital outcomes using hematological parameters.
Results
Median age of the study participants was 54 years (IQR=66-42 years), males comprised 63% of the participants. Both Neutrophil-Lymphocyte ratio (NLR) and d-NLR had almost high sensitivity, low specificity and predictability for disease severity and outcome of
infection. Lymphocyte-monocyte ratio was found to be significantly associated with disease severity and outcome. Thrombocytopenia was common in severe patients requiring ICU admission.
Conclusion
Complete hemogram at the time of presentation to the health facility can act as simple and effective tool to assess the disease severity and prognosis of Covid-19 infection.
References
World Health Organization. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020. [Internet] Available online: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-atthe-media-briefing-on-covid-19---11-march-2020 (last accessed on 1 July 2022).
Gualano MR, Corradi A, Voglino G, Bert F, Siliquini R. Beyond COVID-19: a cross-sectional study in Italy exploring the covid collateral impacts on healthcare services. Health Policy. 2021 Jul;125(7):869-876.
Levine RL, Rathmell WK. COVID-19 impact on early career investigators: a call for action. Nat Rev Cancer. 2020 Jul;20(7):357-358.
Zhu W, Xu D, Li H, Xu G, Tian J, Lyu L, et al. Impact of Long-Term Home Quarantine on Mental Health and Physical Activity of People in Shanghai During the COVID-19 Pandemic. Front Psychiatry. 2022 Jan 27;12:782753..
Vallée A. Heterogeneity of the COVID-19 Pandemic in the United States of America: A Geo-Epidemiological Perspective. Front Public Health. 2022 Jan 26;10:818989.
Gaudart J, Landier J, Huiart L, Legendre E, Lehot L, Bendiane MK, et al. Factors associated with the spatial heterogeneity of the first wave of COVID-19 in France: a nationwide geo-epidemiological study. Lancet Public Health. 2021 Apr;6(4):e222-e231.
Worldometer. COVID-19 [Internet] Available from:https://www.worldometers.info/coronavirus/[last accessed on 17 th May 2023]
Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020 Feb;91:264-266.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506
de Bruin S, Bos LD, van Roon MA, Tuip-de Boer AM, Schuurman AR, Koel-Simmelinck MJA, et al; Amsterdam UMC COVID-19 Biobank Investigators. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine. 2021 May;67:103378.
Xie P, Ma W, Tang H, Liu D. Severe COVID-19: A Review of Recent Progress With a Look Toward the Future. Front Public Health. 2020 May 13;8:189.
Rahman A, Niloofa R, Jayarajah U, De Mel S, Abeysuriya V, Seneviratne SL. Hematological Abnormalities in COVID-19: A Narrative Review. Am J Trop Med Hyg. 2021 Feb 19;104(4):1188-1201.
Dettorre GM, Dolly S, Loizidou A, Chester J, Jackson A, Mukherjee U, Zambelli A, et al. Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the On Covid Inflammatory Score. J Immunother Cancer. 2021 Mar;9(3):e002277
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943.
Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020 Jul;84:106504.
CURB-65 Score, MDcal [Internet] Available from:https://www.mdcalc.com/calc/324/curb-65-score-pneumonia severity#:~:text=The%20CURB%2D65%20calculator%20can,to%20a%20variety%20of%20factors. (last accessed on 10 th December 2022)
Zinellu A, Zinellu E, Pau MC, Carru C, Pirina P, Fois AG et al. A Comprehensive Systematic Review and Meta-Analysis of the Association between the Neutrophil-to-Lymphocyte Ratio and Adverse Outcomes in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. J Clin Med. 2022 Jun 11;11(12):3365.
Wu M, Zhou L, Zhu D, Lai T, Chen Z, Shen H. Hematological indices as simple, inexpensive and practical severity markers of obstructive sleep apnea syndrome: a meta-analysis. J Thorac Dis. 2018 Dec;10(12):6509-6521.
MikolaschT, Sahota J, Garthwaite H, Win T, Ganeshan B, Heightman M, Hoy L, Machado M, Groves, A, Porter J. S142 Neutrophil Lymphocyte Ratio (NLR) as a Predictive Biomarker in Idiopathic Pulmonary Fibrosis (IPF). BMJ 2018, 73, A88.2–A89.
Huang WJ, Huang GT, Zhan QM, Chen JL, Luo WT, Wu LH, et al. The neutrophil to lymphocyte ratio as a novel predictor of asthma and its exacerbation: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2020 Nov;24(22):11719- 11728.
Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020 Sep;57(6):389-399.
Karimi A, Shobeiri P, Kulasinghe A, Rezaei N. Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis. Front Immunol. 2021 Oct 22;12:741061.
Cheng B, Hu J, Zuo X, Chen J, Li X, Chen Y, et al. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort. Clin Microbiol Infect. 2020 Oct;26(10):1400-1405.
Pan F, Yang L, Li Y, Liang B, Li L, Ye T, et al. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study. Int J Med Sci. 2020 May 18;17(9):1281-1292
Fois SS, Zinellu E, Zinellu A, Merella M, Pau MC, Carru C, et al. Comparison of Clinical Features, Complete Blood Count Parameters, and Outcomes between Two Distinct Waves of COVID-19: A Monocentric Report from Italy. Healthcare (Basel). 2022 Nov 30;10(12):2427.
Cheng B, Hu J, Zuo X, Chen J, Li X, Chen Y, et al, Deng A. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort. Clin Microbiol Infect. 2020 Oct;26(10):1400-1405.
Kosidło JW, Wolszczak-Biedrzycka B, Matowicka-Karna J, Dymicka-Piekarska V, Dorf J. Clinical Significance and Diagnostic Utility of NLR, LMR, PLR and SII in the Course of COVID-19: A Literature Review. J Inflamm Res. 2023 Feb 11;16:539-562.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Indranil Thakur, Arup Chakraborty, Ria Mukherjee, Ankush Banerjee, Suprabhat Das, Utpal Dan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en